miRagen Therapeutics Provides Corporate Update
Mar 31, 2017 20:05 pm UTC| Business
BOULDER, Colo., March 31, 2017 -- miRagen Therapeutics, Inc. (Nasdaq:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today reported recent...
Calix Announces Resignation of Chief Financial Officer
Mar 31, 2017 20:01 pm UTC| Business
PETALUMA, Calif., March 31, 2017 -- Calix, Inc. (NYSE:CALX) today announced that William Atkins, Executive Vice President and Chief Financial Officer, has given notice that he will be leaving the Company on May 19, 2017...
Calix Announces Resignation of Chief Financial Officer
Mar 31, 2017 20:02 pm UTC| Business
PETALUMA, Calif., March 31, 2017 -- Calix, Inc. (NYSE:CALX) today announced that William Atkins, Executive Vice President and Chief Financial Officer, has given notice that he will be leaving the Company on May 19, 2017...
FlexShopper, Inc. Reports Full Year 2016 Results and 130% Revenue Growth
Mar 31, 2017 20:01 pm UTC| Business
BOCA RATON, Fla., March 31, 2017 -- FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper”), a leading national online lease-to-own (“LTO”) retailer and LTO payment solution provider, announced today its results of operations...
Jounce Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes
Mar 31, 2017 20:01 pm UTC| Business
CAMBRIDGE, Mass., March 31, 2017 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient...
Equity Bancshares, Inc. Will Announce Q1 2017 Results on April 20, 2017
Mar 31, 2017 20:01 pm UTC| Business
WICHITA, Kan., March 31, 2017 -- Equity Bancshares, Inc. (NASDAQ:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its first quarter 2017 results after the market closes on Thursday,...
Acura Pharmaceuticals Announces Fourth Quarter 2016 and Full Year 2016 Financial Results
Mar 31, 2017 20:01 pm UTC| Business
PALATINE, Ill., March 31, 2017 -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovatingabuse deterrent drugs, announced today financial results for the year and three months ended...